FDA Denies Claim Linking Hydrolyzed Infant Formula To Reduced Allergies
This article was originally published in The Tan Sheet
Executive Summary
There is "no credible scientific evidence" to support a qualified health claim linking consumption of 100% partially hydrolyzed whey protein infant formula (PHF-W) to a reduced risk of the development of food allergies, FDA concludes in a May 11 letter to petitioner Nestlé USA
You may also be interested in...
Gerber reboots whey protein formula petition
Nestle Infant Nutrition asks FDA to allow a qualified health claim that 100-percent whey-protein partially hydrolyzed infant formula "may reduce the risk of developing the most common allergic disease of infancy -- atopic dermatitis" in infants not exclusively breastfed. The subsidiary of Florham Park, N.J.-based Gerber Products adds in a May 14 citizen 1petition that partially hydrolyzed formulas are not meant to treat existing food allergy symptoms. FDA posted the petition July 21. In 2005, FDA denied a request by Nestle Infant Nutrition, then a Nestle USA division, for a food allergy QHC for whey protein formula (2"The Tan Sheet" May 22, 2006). The firm says its resubmitted petition has a reworded claim and includes additional supporting science
Gerber reboots whey protein formula petition
Nestle Infant Nutrition asks FDA to allow a qualified health claim that 100-percent whey-protein partially hydrolyzed infant formula "may reduce the risk of developing the most common allergic disease of infancy -- atopic dermatitis" in infants not exclusively breastfed. The subsidiary of Florham Park, N.J.-based Gerber Products adds in a May 14 citizen 1petition that partially hydrolyzed formulas are not meant to treat existing food allergy symptoms. FDA posted the petition July 21. In 2005, FDA denied a request by Nestle Infant Nutrition, then a Nestle USA division, for a food allergy QHC for whey protein formula (2"The Tan Sheet" May 22, 2006). The firm says its resubmitted petition has a reworded claim and includes additional supporting science
Gerber reboots whey protein formula petition
Nestle Infant Nutrition asks FDA to allow a qualified health claim that 100-percent whey-protein partially hydrolyzed infant formula "may reduce the risk of developing the most common allergic disease of infancy -- atopic dermatitis" in infants not exclusively breastfed. The subsidiary of Florham Park, N.J.-based Gerber Products adds in a May 14 citizen 1petition that partially hydrolyzed formulas are not meant to treat existing food allergy symptoms. FDA posted the petition July 21. In 2005, FDA denied a request by Nestle Infant Nutrition, then a Nestle USA division, for a food allergy QHC for whey protein formula (2"The Tan Sheet" May 22, 2006). The firm says its resubmitted petition has a reworded claim and includes additional supporting science